Article ID Journal Published Year Pages File Type
5668686 Journal of Infection 2017 4 Pages PDF
Abstract

•Combining anti-HIV antibody and drugs showed synergistic anti-HIV-1 activity.•Anti-HIV antibody/drug combinations are effective against drug-resistant mutants.•Combining drugs with different targets increase drug-resistance barrier.•Drug combinations lead to dose-reduction, thus reducing drugs' cost and toxicity.

Related Topics
Life Sciences Immunology and Microbiology Applied Microbiology and Biotechnology
Authors
, , , , , , , ,